Cornerstone Advisors’s Idexx Laboratories IDXX Stock Holding History

Cornerstone Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14.9M	Buy	28,295 +5,508	+24%	+$3.09M	0.49%	60
2026 Q1	$12.8M	Buy	22,787 +8,617	+61%	+$5.53M	0.47%	68
2025 Q4	$9.59M	Buy	+14,170	New	+$9.65M	0.32%	91
2025 Q3	–	Sell	-700	Closed	-$375K	–	262
2025 Q2	$375K	Hold	700	–	–	0.01%	254
2025 Q1	$294K	Hold	700	–	–	0.01%	253
2024 Q4	$289K	Hold	700	–	–	0.01%	250
2024 Q3	$354K	Hold	700	–	–	0.01%	262
2024 Q2	$341K	Sell	700 -1,500	-68%	-$753K	0.01%	282
2024 Q1	$1.19M	Hold	2,200	–	–	0.05%	256
2023 Q4	$1.22M	Hold	2,200	–	–	0.05%	243
2023 Q3	$962K	Buy	+2,200	New	+$1.1M	0.04%	260
2022 Q2	–	Sell	-2,000	Closed	-$1.09M	–	193
2022 Q1	$1.09M	Sell	2,000 -4,000	-67%	-$2.1M	0.06%	153
2021 Q4	$3.95M	Hold	6,000	–	–	0.21%	110
2021 Q3	$3.73M	Hold	6,000	–	–	0.22%	120
2021 Q2	$3.79M	Hold	6,000	–	–	0.22%	125
2021 Q1	$2.94M	Hold	6,000	–	–	0.26%	99
2020 Q4	$3M	Buy	+6,000	New	+$2.68M	0.26%	90

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Cornerstone Advisors's IDXX Position: Q2 2026 in Review

Cornerstone Advisors increased its Idexx Laboratories (IDXX) stake by 24% in Q2 2026, buying an estimated $3.09M and bringing the position to 28,295 shares worth $14.9M. The position accounts for 0.49% of the portfolio, ranked #60.

Cornerstone Advisors first reported a position in IDXX in Q4 2020 and has held it in 17 quarters since. 1,300 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Cornerstone Advisors held 28,295 shares of Idexx Laboratories worth $14.9M as of Q2 2026.
Cornerstone Advisors bought 5,508 Idexx Laboratories shares in Q2 2026, an estimated $3.09M.
Idexx Laboratories made up 0.49% of Cornerstone Advisors's portfolio in Q2 2026, its #60 holding.
Cornerstone Advisors first reported a position in Idexx Laboratories in Q4 2020 and has held it in 17 quarters since.
1,300 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Cornerstone Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.